Works by Sheng, Jindong

Results: 13

Tislelizumab (anti-PD-1) plus chemotherapy as neoadjuvant therapy for patients with stage IB3/IIA2 cervical cancer (NATIC): a prospective, single-arm, phase II study.

Published in:

Signal Transduction & Targeted Therapy, 2025, v. 10, n. 1, p. 1, doi. 10.1038/s41392-025-02294-9

By:

Sheng, Jindong;
Luo, Haitao;
Liu, Xiangyu;
Liu, Chunyan;
Zhou, Wenhao;
Zhao, Yujie;
Liu, Ruoyan;
Li, Dan;
Xu, Changxiao;
Yang, Bo;
Liu, Ying;
Fu, Xin;
Bao, Lewen;
Wang, Ke;
Hao, Jihui;
Liu, Wenxin

Publication type:

Article

The Silencing of CCND2 by Promoter Aberrant Methylation in Renal Cell Cancer and Analysis of the Correlation between CCND2 Methylation Status and Clinical Features.

Published in:

PLoS ONE, 2016, v. 11, n. 9, p. 1, doi. 10.1371/journal.pone.0161859

By:

Wang, Lu;
Cui, Yun;
Zhang, Lian;
Sheng, Jindong;
Yang, Yang;
Kuang, Guanyu;
Fan, Yu;
Zhang, Qian;
Jin, Jie

Publication type:

Article

Potent antitumour of the mTORC1/2 dual inhibitor AZD2014 in docetaxel‐sensitive and docetaxel‐resistant castration‐resistant prostate cancer cells.

Published in:

Journal of Cellular & Molecular Medicine, 2021, v. 25, n. 5, p. 2436, doi. 10.1111/jcmm.16155

By:

Li, Senmao;
Sheng, Jindong;
Liu, Zhenhua;
Fan, Yu;
Zhang, Cuijian;
Lv, Tianjing;
Hu, Shuai;
Jin, Jie;
Yu, Wei;
Song, Yi

Publication type:

Article

Infiltrating CD4+ T cells attenuate chemotherapy sensitivity in prostate cancer via CCL5 signaling.

Published in:

Prostate, 2019, v. 79, n. 9, p. 1018, doi. 10.1002/pros.23810

By:

Xiang, Peng;
Jin, Song;
Yang, Yang;
Sheng, Jindong;
He, Qun;
Song, Yi;
Yu, Wei;
Hu, Shuai;
Jin, Jie

Publication type:

Article

Activation of cGMP/PKG/p65 signaling associated with PDE5‐Is downregulates CCL5 secretion by CD8 <sup>+</sup> T cells in benign prostatic hyperplasia.

Published in:

Prostate, 2019, v. 79, n. 8, p. 909, doi. 10.1002/pros.23801

By:

Jin, Song;
Xiang, Peng;
Liu, Jie;
Yang, Yang;
Hu, Shuai;
Sheng, Jindong;
He, Qun;
Yu, Wei;
Han, Wenke;
Jin, Jie;
Peng, Jing

Publication type:

Article

T cell receptor β-chain repertoire analysis reveals the association between neoantigens and tumour-infiltrating lymphocytes in multifocal papillary thyroid carcinoma.

Published in:

International Journal of Cancer, 2017, v. 141, n. 2, p. 377, doi. 10.1002/ijc.30743

By:

Lu, Zheming;
Zhang, Chaoting;
Sheng, Jindong;
Shen, Jing;
Liu, Baoguo

Publication type:

Article

Methylation of DACT2 Promotes Papillary Thyroid Cancer Metastasis by Activating Wnt Signaling.

Published in:

PLoS ONE, 2014, v. 9, n. 11, p. 1, doi. 10.1371/journal.pone.0112336

By:

Zhao, Zhiyan;
Herman, James G.;
Brock, Malcolm V.;
Sheng, Jindong;
Zhang, Meiying;
Liu, Baoguo;
Guo, Mingzhou

Publication type:

Article

Development of a Dendritic Cell/Tumor Cell Fusion Cell Membrane Nano-Vaccine for the Treatment of Ovarian Cancer.

Published in:

Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.828263

By:

Zhang, Lei;
Zhao, Wei;
Huang, Jinke;
Li, Fangxuan;
Sheng, Jindong;
Song, Hualin;
Chen, Ying

Publication type:

Article

Estrogen and G protein-coupled estrogen receptor accelerate the progression of benign prostatic hyperplasia by inducing prostatic fibrosis.

Published in:

Cell Death & Disease, 2022, v. 13, n. 6, p. 1, doi. 10.1038/s41419-022-04979-3

By:

Yang, Yang;
Sheng, Jindong;
Hu, Shuai;
Cui, Yun;
Xiao, Jing;
Yu, Wei;
Peng, Jing;
Han, Wenke;
He, Qun;
Fan, Yu;
Niu, Yuanjie;
Lin, Jun;
Tian, Ye;
Chang, Chawnshang;
Yeh, Shuyuan;
Jin, Jie

Publication type:

Article

M2 macrophage-mediated interleukin-4 signalling induces myofibroblast phenotype during the progression of benign prostatic hyperplasia.

Published in:

Cell Death & Disease, 2018, v. 9, n. 7, p. 1, doi. 10.1038/s41419-018-0744-1

By:

Sheng, Jindong;
Yang, Yang;
Cui, Yun;
He, Shiming;
Wang, Lu;
Liu, Libo;
He, Qun;
Lv, Tianjing;
Han, Wenke;
Yu, Wei;
Hu, Shuai;
Jin, Jie

Publication type:

Article

Combination of Chemotherapy and Photodynamic Therapy with Oxygen Self-Supply in the Form of Mutual Assistance for Cancer Therapy.

Published in:

International Journal of Nanomedicine, 2021, v. 16, p. 3679, doi. 10.2147/IJN.S298146

By:

Chen, Ying;
Zhang, Lei;
Li, Fangxuan;
Sheng, Jindong;
Xu, Changxiao;
Li, Dan;
Yu, Hu;
Liu, Wenxin

Publication type:

Article

RPL35A drives ovarian cancer progression by promoting the binding of YY1 to CTCF promoter.

Published in:

Journal of Cellular & Molecular Medicine, 2024, v. 28, n. 6, p. 1, doi. 10.1111/jcmm.18115

By:

Wu, Huijuan;
Xia, Liangbin;
Sun, Lu;
Li, Dan;
Liu, Xiangyu;
Song, Hualin;
Sheng, Jindong;
Wang, Ke;
Feng, Qinmei

Publication type:

Article

Clonality analysis of multifocal papillary thyroid carcinoma by using genetic profiles.

Published in:

Journal of Pathology, 2016, v. 239, n. 1, p. 72, doi. 10.1002/path.4696

By:

Lu, Zheming;
Sheng, Jindong;
Zhang, Yujie;
Deng, Jianhua;
Li, Yong;
Lu, Aiping;
Zhang, Juan;
Yu, Huan;
Zhang, Min;
Xiong, Zikai;
Yan, Hai;
Diplas, Bill H;
Lu, Youyong;
Liu, Baoguo

Publication type:

Article